Brief-Bristol-Myers spokesperson says co implemented a voluntary pause to review clinical data across their Zola-cel program
BMY•Bristol-Myers says it paused Zola-cel program review
-
Sept. 1 (Reuters) - Bristol-Myers Squibb Company BMY.N:
-
Bristol-Myers Squibb spokesperson - implemented a voluntary pause to review clinical data across our Zola-cel program
